General Information of Drug Transporter (DT)
DT ID DTD0500 Transporter Info
Gene Name SLCO2A1
Transporter Name Organic anion transporting polypeptide 2A1
Gene ID
6578
UniProt ID
Q92959
Post-Translational Modification of This DT
Overview of SLCO2A1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLCO2A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

134

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLCO2A1 Asparagine 134 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLCO2A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

478

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLCO2A1 Asparagine 478 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLCO2A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

491

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLCO2A1 Asparagine 491 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          7 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLCO2A1 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

10

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLCO2A1 Serine 10 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLCO2A1 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

13

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLCO2A1 Serine 13 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLCO2A1 [4] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

16

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLCO2A1 Serine 16 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLCO2A1 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

18

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLCO2A1 Serine 18 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLCO2A1 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

304

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLCO2A1 Serine 304 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLCO2A1 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

307

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLCO2A1 Serine 307 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLCO2A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

625

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLCO2A1 Serine 625 has the potential to affect its expression or activity.

  Threonine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLCO2A1 [4] , [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

15

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLCO2A1 Threonine 15 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLCO2A1 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

17

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLCO2A1 Threonine 17 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLCO2A1 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

402

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLCO2A1 Threonine 402 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLCO2A1 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

403

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLCO2A1 Threonine 403 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLCO2A1 [9]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

606

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLCO2A1 Tyrosine 606 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: SO2A1_HUMAN)
2 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
3 Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics. 2013 Oct 8;91:286-96.
4 Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
5 Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell. 2020 Dec 17;80(6):1104-1122.e9.
6 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
7 Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
8 Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics. 2015 Jan;15(2-3):508-519.
9 A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples. J Proteome Res. 2012 Nov 2;11(11):5311-22.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.